BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37580498)

  • 1. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
    Pulm Ther; 2023 Sep; 9(3):411-427. PubMed ID: 37580498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI; Edin AS; Astafieva NG; Lopatin AS; Sidorenko IV; Ukhanova OP; Khanova FM
    Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
    Berger W; Meltzer EO; Amar N; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Bousquet J
    Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R; Nguyen DT; Kuhl HC
    Immun Inflamm Dis; 2018 Dec; 6(4):456-464. PubMed ID: 30306729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE; Meltzer EO
    Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
    Klimek L; Berger WE; Bousquet J; Keith PK; Smith P; Sole D; Scadding G; Kuhl HC; Nguyen DT; Kopietz F; Koltun A
    Int Arch Allergy Immunol; 2021; 182(11):1026-1035. PubMed ID: 34082425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
    Scadding G; Price D; El-Shanawany T; Ahmed S; Ray J; Sargur R; Kumar N
    BMJ Open; 2017 Apr; 7(4):e014777. PubMed ID: 28442578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis.
    Zhong Z; Xun Y; Shi X; Guan B; Wang M
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2457-2464. PubMed ID: 34415405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Life Effectiveness of MP-AzeFlu (Dymista
    Stjärne P; Nguyen DT; Kuhl HC
    Pragmat Obs Res; 2023; 14():1-11. PubMed ID: 36628265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
    Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers.
    Qi W; Liu Y; Xue W; Li K; Gorski JC; Liu M; Yan T; Nguyen DT; Ramalingam RK
    J Asthma Allergy; 2023; 16():667-677. PubMed ID: 37409000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis.
    Bousquet J; Klimek L; Kuhl HC; Nguyen DT; Ramalingam RK; Canonica GW; Berger WE
    Front Allergy; 2023; 4():1244012. PubMed ID: 37920410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis.
    van Weissenbruch R; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; Kuhl HC; Pohl W; Scadding GK; Price D; Mullol J
    J Asthma Allergy; 2020; 13():633-645. PubMed ID: 33293835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
    Haahr PA; Jacobsen C; Christensen ME
    Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells.
    Berger WE; Bachert C; Allara R; Koltun A; Kopietz F; Maus JG; D'Addio AD
    J Asthma Allergy; 2020; 13():187-192. PubMed ID: 32547111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US.
    Prenner BM
    J Asthma Allergy; 2016; 9():135-43. PubMed ID: 27468241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma.
    Price D; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
    Clin Mol Allergy; 2020; 18():15. PubMed ID: 32782442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
    Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
    Pulm Ther; 2024 Mar; 10(1):143-144. PubMed ID: 38099987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.